ClinicalTrials.gg
Active, not recruitingNCT07734805Updated Jul 30, 2026

Radiological Diagnosis of Pediatric Neck Swellings

An observational study in Lipoma, Branchial Cleft Anomalies and Cystic Hygroma (Macro-cystic Lymphatic Malformation), sponsored by Sohag University. Active, not recruiting at 1 site in Egypt. Open to participants aged 1 Month to 16 Years. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by Sohag University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
50
Ages
1 Month to 16 Years
Sex
All
01

Study summary

Various diagnostic imaging modalities have been utilized in the assessment of pediatric neck lesions, including gray-scale and Doppler ultrasonography, conventional and three-dimensional computed tomography (CT), magnetic resonance imaging (MRI), and MR angiography, each offering distinct advantages and limitations.

Read the detailed description

Although gray-scale ultrasonography and duplex imaging are considered the first-line modalities for evaluating superficial neck masses due to their accessibility, feasibility, and cost-effectiveness, the depth of high-frequency transducers is limited, particularly in large lesions with uncertain origin or extent. Consequently, cross-sectional imaging modalities such as CT and MRI play an important complementary role by improving diagnostic accuracy and providing detailed assessment of deeper structural involvement. [2,3]

Radiological characterization aims eventually to guide management by identifying the most appropriate subsequent step, which may include clinical observation, interval imaging follow-up, tissue sampling, surgical intervention, embolization, or sclerotherapy.

02

Conditions studied

  • Lipoma
  • Branchial Cleft Anomalies
  • Cystic Hygroma (Macro-cystic Lymphatic Malformation)
  • Rhabdomyosarcoma
  • Lymphadenitis
  • Neck Abscess
  • Myxoid Chondrosarcoma
  • Hemangiomas of Infancy
  • Thyroglossal Duct Cysts

Keywords

  • neck swellings
  • neck abscess
  • lymphadenitis
  • branchial cleft cyst
  • cervical lymphadenitis
  • nodal abscess
  • chondrosacroma
  • neck mass
  • hemangioma
  • thyroglossal duct cyst
03

In context

Lipoma

22 studies on the registry are indexed under Lipoma; 6 are open to participants now.

Browse Lipoma studies →

Lead sponsor

Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pediatric patients referred from pediatrics, ENT, surgery, oncology or emergency departments for radiological evaluation of a neck swelling/mass

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pediatric patients referred from pediatrics, ENT, surgery, oncology or emergency departments for radiological evaluation of a neck swelling/mass

Exclusion criteria

Exclusion Criteria:

  • Previous surgery (post operative patients).
  • to intravenous contrast administration when contrast enhanced studies are required (e.g. history of severe contrast allergy).
  • Contraindication to MRI (e.g., severe claustrophobia non-manageable by sedation).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
50 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • pediatric patients with neck swellings

    Pediatric patients referred to Sohag University Hospital for radiological evaluation of a neck swelling or mass. Patients will undergo clinical assessment and appropriate imaging evaluation, including gray-scale and Doppler ultrasonography as the initial imaging modality, with CT and/or MRI performed when clinically indicated. Imaging findings will be assessed for lesion detection, anatomical localization, tissue characterization, differential diagnosis, and assessment of involvement of adjacent structures.

06

What researchers measure

Primary outcomes

  1. Diagnostic accuracy of tissue characterization of pediatric neck swellings

    Accuracy of multimodality imaging in characterizing pediatric neck swellings according to their imaging features and tissue composition, including cystic, solid, vascular, inflammatory, or other relevant characteristics, compared with the final diagnosis based on histopathological examination, microbiological assessment, surgical findings, or clinical and imaging follow-up, as applicable.

    Time frame: From baseline imaging assessment until establishment of the final diagnosis, or up to 6 months after initial imaging, whichever comes first.

Other outcomes

  1. Sensitivity of multimodality imaging for diagnosis of pediatric neck swellings

    Percentage of patients with a specific final diagnosis correctly identified by imaging, using the final diagnosis as the reference standard; compared with the final diagnosis based on histopathological examination, microbiological assessment, surgical findings, or clinical and imaging follow-up, as applicable.

    Time frame: From baseline imaging assessment until establishment of the final diagnosis, or up to 6 months after initial imaging, whichever comes first.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided — Individual participant data will not be shared with other researchers. Data will be analyzed and reported in aggregate form, and participant confidentiality will be maintained. Any data used for analysis will be anonymized and securely stored in accordance with institutional ethical requirements and applicable data protection regulations.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2026 (actual). Primary completion is estimated for Jan 2027, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 24, 2026
First posted
Jul 29, 2026
StartActual
Feb 20, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Feb 1, 2027
Last update
Jul 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07734805
Lead sponsor
Sohag University
Responsible party
Salma Mohamed Hassan (Resident, Sohag University) — Principal investigator
First posted
Jul 29, 2026
Start date
Feb 20, 2026
Primary completion
Jan 1, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Jul 30, 2026

Study contacts

Mohamad Zaki Ali, MD
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion